Cargando…

Diabetic Cardiomyopathy as a Clinical Entity: Is It a Myth?

Dilated cardiomyopathy (DCM) is a common form of cardiomyopathy that affects the cardiac muscle. It is a life-threatening condition that causes heart failure as it decreases the myocardial ability to pump sufficient blood throughout the body. Numerous causes trigger DCM without pathophysiology; howe...

Descripción completa

Detalles Bibliográficos
Autores principales: Zaveri, Mitul P, Perry, Jamal C, Schuetz, Tayná M, Memon, Mohammad D, Faiz, Sadaf, Cancarevic, Ivan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cureus 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7681757/
https://www.ncbi.nlm.nih.gov/pubmed/33240696
http://dx.doi.org/10.7759/cureus.11100
_version_ 1783612603402027008
author Zaveri, Mitul P
Perry, Jamal C
Schuetz, Tayná M
Memon, Mohammad D
Faiz, Sadaf
Cancarevic, Ivan
author_facet Zaveri, Mitul P
Perry, Jamal C
Schuetz, Tayná M
Memon, Mohammad D
Faiz, Sadaf
Cancarevic, Ivan
author_sort Zaveri, Mitul P
collection PubMed
description Dilated cardiomyopathy (DCM) is a common form of cardiomyopathy that affects the cardiac muscle. It is a life-threatening condition that causes heart failure as it decreases the myocardial ability to pump sufficient blood throughout the body. Numerous causes trigger DCM without pathophysiology; however, the key concept is a decrease in the systolic function of either the left ventricle or of both the left and right ventricles. Long-term diabetes plays an important role in the pathogenesis of DCM in the form of diabetic cardiomyopathy. Diabetic cardiomyopathy is a non-ischemic form of DCM, which is associated with diabetes. It is unrelated to atherosclerosis and hypertension. The PubMed and Google Scholar databases were used to identify the relevant studies related to diabetes and DCM. We found that diabetes was associated with cardiac muscle injury by activating the renin-angiotensin-aldosterone system, myocardial inflammation, and fibrosis. Based on the available data, we concluded that there is strong evidence to support the interrelation of DCM and diabetes.
format Online
Article
Text
id pubmed-7681757
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Cureus
record_format MEDLINE/PubMed
spelling pubmed-76817572020-11-24 Diabetic Cardiomyopathy as a Clinical Entity: Is It a Myth? Zaveri, Mitul P Perry, Jamal C Schuetz, Tayná M Memon, Mohammad D Faiz, Sadaf Cancarevic, Ivan Cureus Cardiology Dilated cardiomyopathy (DCM) is a common form of cardiomyopathy that affects the cardiac muscle. It is a life-threatening condition that causes heart failure as it decreases the myocardial ability to pump sufficient blood throughout the body. Numerous causes trigger DCM without pathophysiology; however, the key concept is a decrease in the systolic function of either the left ventricle or of both the left and right ventricles. Long-term diabetes plays an important role in the pathogenesis of DCM in the form of diabetic cardiomyopathy. Diabetic cardiomyopathy is a non-ischemic form of DCM, which is associated with diabetes. It is unrelated to atherosclerosis and hypertension. The PubMed and Google Scholar databases were used to identify the relevant studies related to diabetes and DCM. We found that diabetes was associated with cardiac muscle injury by activating the renin-angiotensin-aldosterone system, myocardial inflammation, and fibrosis. Based on the available data, we concluded that there is strong evidence to support the interrelation of DCM and diabetes. Cureus 2020-10-22 /pmc/articles/PMC7681757/ /pubmed/33240696 http://dx.doi.org/10.7759/cureus.11100 Text en Copyright © 2020, Zaveri et al. http://creativecommons.org/licenses/by/3.0/ This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
spellingShingle Cardiology
Zaveri, Mitul P
Perry, Jamal C
Schuetz, Tayná M
Memon, Mohammad D
Faiz, Sadaf
Cancarevic, Ivan
Diabetic Cardiomyopathy as a Clinical Entity: Is It a Myth?
title Diabetic Cardiomyopathy as a Clinical Entity: Is It a Myth?
title_full Diabetic Cardiomyopathy as a Clinical Entity: Is It a Myth?
title_fullStr Diabetic Cardiomyopathy as a Clinical Entity: Is It a Myth?
title_full_unstemmed Diabetic Cardiomyopathy as a Clinical Entity: Is It a Myth?
title_short Diabetic Cardiomyopathy as a Clinical Entity: Is It a Myth?
title_sort diabetic cardiomyopathy as a clinical entity: is it a myth?
topic Cardiology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7681757/
https://www.ncbi.nlm.nih.gov/pubmed/33240696
http://dx.doi.org/10.7759/cureus.11100
work_keys_str_mv AT zaverimitulp diabeticcardiomyopathyasaclinicalentityisitamyth
AT perryjamalc diabeticcardiomyopathyasaclinicalentityisitamyth
AT schuetztaynam diabeticcardiomyopathyasaclinicalentityisitamyth
AT memonmohammadd diabeticcardiomyopathyasaclinicalentityisitamyth
AT faizsadaf diabeticcardiomyopathyasaclinicalentityisitamyth
AT cancarevicivan diabeticcardiomyopathyasaclinicalentityisitamyth